Literature DB >> 24755488

Heparan sulfate signaling in cancer.

Erik H Knelson1, Jasmine C Nee2, Gerard C Blobe3.   

Abstract

Heparan sulfate (HS) is a biopolymer consisting of variably sulfated repeating disaccharide units. The anticoagulant heparin is a highly sulfated intracellular variant of HS. HS has demonstrated roles in embryonic development, homeostasis, and human disease via non-covalent interactions with numerous cellular proteins, including growth factors and their receptors. HS can function as a co-receptor by enhancing receptor-complex formation. In other contexts, HS disrupts signaling complexes or serves as a ligand sink. The effects of HS on growth factor signaling are tightly regulated by the actions of sulfyltransferases, sulfatases, and heparanases. HS has important emerging roles in oncogenesis, and heparin derivatives represent potential therapeutic strategies for human cancers. Here we review recent insights into HS signaling in tumor proliferation, angiogenesis, metastasis, and differentiation. A cancer-specific understanding of HS signaling could uncover potential therapeutic targets in this highly actionable signaling network.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  heparan sulfate; heparanase; heparin; metastasis; sulfatase; sulfyltransferase

Mesh:

Substances:

Year:  2014        PMID: 24755488      PMCID: PMC4065786          DOI: 10.1016/j.tibs.2014.03.001

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  135 in total

Review 1.  Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

Authors:  R V Iozzo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Heparan sulfate proteoglycan expression in human lung-cancer cells.

Authors:  K Nackaerts; E Verbeken; G Deneffe; B Vanderschueren; M Demedts; G David
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

3.  TRF2 inhibits a cell-extrinsic pathway through which natural killer cells eliminate cancer cells.

Authors:  Annamaria Biroccio; Julien Cherfils-Vicini; Adeline Augereau; Sébastien Pinte; Serge Bauwens; Jing Ye; Thomas Simonet; Béatrice Horard; Karine Jamet; Ludovic Cervera; Aaron Mendez-Bermudez; Delphine Poncet; Renée Grataroli; Claire T'kint de Rodenbeeke; Erica Salvati; Angela Rizzo; Pasquale Zizza; Michelle Ricoul; Céline Cognet; Thomas Kuilman; Helene Duret; Florian Lépinasse; Jacqueline Marvel; Els Verhoeyen; François-Loïc Cosset; Daniel Peeper; Mark J Smyth; Arturo Londoño-Vallejo; Laure Sabatier; Vincent Picco; Gilles Pages; Jean-Yves Scoazec; Antonella Stoppacciaro; Carlo Leonetti; Eric Vivier; Eric Gilson
Journal:  Nat Cell Biol       Date:  2013-06-23       Impact factor: 28.824

4.  Genome-wide identification and validation of a novel methylation biomarker, SDC2, for blood-based detection of colorectal cancer.

Authors:  TaeJeong Oh; Nayoung Kim; Youngho Moon; Myung Soon Kim; Benjamin D Hoehn; Chan Hee Park; Tae Soo Kim; Nam Kyu Kim; Hyun Cheol Chung; Sungwhan An
Journal:  J Mol Diagn       Date:  2013-06-07       Impact factor: 5.568

5.  Modified heparins inhibit integrin alpha(IIb)beta(3) mediated adhesion of melanoma cells to platelets in vitro and in vivo.

Authors:  Chunmei Zhang; Yan Liu; YanGuang Gao; Jian Shen; Sheng Zheng; Min Wei; XianLu Zeng
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

6.  Amino acid determinants that drive heparan sulfate assembly in a proteoglycan.

Authors:  L Zhang; J D Esko
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

Review 7.  Heparin and heparan sulfate: structure and function.

Authors:  Dallas L Rabenstein
Journal:  Nat Prod Rep       Date:  2002-06       Impact factor: 13.423

8.  The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.

Authors:  Hector R Contreras; Rodrigo A Ledezma; Jorge Vergara; Federico Cifuentes; Cristina Barra; Pablo Cabello; Ivan Gallegos; Bernardo Morales; Christian Huidobro; Enrique A Castellón
Journal:  Urol Oncol       Date:  2009-05-17       Impact factor: 3.498

9.  Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours.

Authors:  D Mennerich; A Vogel; I Klaman; E Dahl; R B Lichtner; A Rosenthal; H-D Pohlenz; K-H Thierauch; A Sommer
Journal:  Eur J Cancer       Date:  2004-06       Impact factor: 9.162

10.  Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells.

Authors:  Kan Ding; Martha Lopez-Burks; José Antonio Sánchez-Duran; Murray Korc; Arthur D Lander
Journal:  J Cell Biol       Date:  2005-11-14       Impact factor: 10.539

View more
  62 in total

1.  Sequencing Heparan Sulfate Using HILIC LC-NETD-MS/MS.

Authors:  Jiandong Wu; Juan Wei; Pradeep Chopra; Geert-Jan Boons; Cheng Lin; Joseph Zaia
Journal:  Anal Chem       Date:  2019-08-29       Impact factor: 6.986

2.  Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.

Authors:  Shuo Wang; Yuan Qu; Pengyan Xia; Yi Chen; Xiaoxiao Zhu; Jing Zhang; Guan Wang; Yong Tian; Jianming Ying; Zusen Fan
Journal:  Cell Res       Date:  2020-05-04       Impact factor: 25.617

Review 3.  Oncogene-directed alterations in cancer cell metabolism.

Authors:  Arvindhan Nagarajan; Parmanand Malvi; Narendra Wajapeyee
Journal:  Trends Cancer       Date:  2016-06-27

4.  GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/β-catenin signaling in lung adenocarcinoma.

Authors:  S Yuan; Z Yu; Q Liu; M Zhang; Y Xiang; N Wu; L Wu; Z Hu; B Xu; T Cai; X Ma; Y Zhang; C Liao; L Wang; P Yang; L Bai; Y Li
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

Review 5.  The Role of Glypicans in Cancer Progression and Therapy.

Authors:  Nan Li; Madeline R Spetz; Mitchell Ho
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

6.  Sulfated glycosaminoglycans mediate prion-like behavior of p53 aggregates.

Authors:  Naoyuki Iwahashi; Midori Ikezaki; Taro Nishikawa; Norihiro Namba; Takashi Ohgita; Hiroyuki Saito; Yoshito Ihara; Toshinori Shimanouchi; Kazuhiko Ino; Kenji Uchimura; Kazuchika Nishitsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-14       Impact factor: 11.205

7.  Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.

Authors:  Anastasia V Suhovskih; Natalya V Domanitskaya; Alexandra Y Tsidulko; Tatiana Y Prudnikova; Vladimir I Kashuba; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

8.  CTGF/VEGFA-activated Fibroblasts Promote Tumor Migration Through Micro-environmental Modulation.

Authors:  Wei Wu; Esther A Zaal; Celia R Berkers; Simone Lemeer; Albert J R Heck
Journal:  Mol Cell Proteomics       Date:  2018-04-18       Impact factor: 5.911

Review 9.  Targeting heparin and heparan sulfate protein interactions.

Authors:  Ryan J Weiss; Jeffrey D Esko; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2017-06-27       Impact factor: 3.876

10.  A Multivariate Mixture Model to Estimate the Accuracy of Glycosaminoglycan Identifications Made by Tandem Mass Spectrometry (MS/MS) and Database Search.

Authors:  Yulun Chiu; Paul Schliekelman; Ron Orlando; Joshua S Sharp
Journal:  Mol Cell Proteomics       Date:  2016-12-09       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.